Sovaldi is a nucleoside-analogue antiviral medication approved for the treatment of chronic hepatitis c infection. It functions by inhibiting the hepatitis c virus rna-dependent rna polymerase, thereby preventing viral replication. The drug is classified as a nucleotide polymerase inhibitor that is activated intracellularly to its triphosphate form. Once phosphorylated, the active metabolite incorporates into the growing rna chain and causes chain termination. This mechanism leads to a rapid decline in viral rna levels in the bloodstream. The sustained reduction of viral load enables the immune system to clear infected hepatocytes over time. The pharmacokinetics of sofosbuvir involve oral absorption, hepatic metabolism to the active triphosphate, and elimination primarily through renal excretion. Its targeted action on viral replication provides a direct therapeutic effect with minimal impact on host cellular processes.

Sovaldi is a brand name for the antiviral drug sofosbuvir. It is used to treat chronic hepatitis c infection in adults. The medication works by targeting a viral enzyme called ns5b polymerase. Inhibition of this enzyme stops the hepatitis c virus from replicating its rna genome. By reducing viral replication, the drug lowers the amount of virus in the bloodstream. This process helps the immune system clear the infection over time. The active metabolite of sofosbuvir, gs-461203, is incorporated into the viral rna chain. This incorporation causes premature termination of viral rna synthesis, leading to viral degradation.

Sovaldi (sofosbuvir) is an antiviral medication used to treat hepatitis c infection. Common side effects include headache, fatigue, and nausea. Some patients may experience insomnia or difficulty sleeping. Skin reactions such as rash or itching can occur. Liver enzyme levels may rise, indicating temporary changes in liver function. In rare cases, serious adverse effects like severe allergic reactions have been reported. Laboratory monitoring is recommended to assess kidney function and blood counts during treatment. These observations are based on clinical trial data and real-world use, but individual experiences may vary.

Sovaldi may cause fatigue in some patients. It can also lead to headache or nausea. Some individuals report elevated liver enzymes. Mild rash or itching has been observed in rare cases. Some patients experience insomnia or sleep disturbances. Some patients experience decreased appetite. Serious but uncommon reactions such as severe allergic responses may occur.